Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15am

Drew Holmes, Ph.D.
Senior Patent Attorney
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

John Krayacich
Vice-President & Head, Business Development & Licensing
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Frederick K. Young, Ph.D.
Due Diligence Head CM and NS
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Get an inside view from members of the IP due diligence group at Novartis as they share their perspectives on the entire diligence process. This oneof- a-kind roundtable discussion will provide insights on:  
  • Developing best practices for potential targets to “put their best foot forward”
  • Avoiding pitfalls during the diligence process
  • Identifying desired qualities for outside counsel
  • Managing budgets
  • Maintaining proper relationships both within and outside of the company